Koshinski Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Buy
2,484
+422
+20% +$82.8K 0.03% 447
2026
Q1
$404K Buy
2,062
+84
+4% +$16.3K 0.03% 492
2025
Q4
$343K Buy
1,978
+142
+8% +$25.9K 0.02% 524
2025
Q3
$350K Buy
1,836
+136
+8% +$24.1K 0.02% 519
2025
Q2
$305K Buy
1,700
+212
+14% +$36.8K 0.02% 530
2025
Q1
$252K Buy
+1,488
New +$244K 0.02% 536
2022
Q2
Sell
-8
Closed -$1.09K 893
2022
Q1
$1.09K Buy
+8
New +$1.11K ﹤0.01% 2052
2021
Q4
Sell
-400
Closed -$58.1K 2172
2021
Q3
$58.1K Buy
+400
New +$58.5K 0.01% 1047

Other funds holding DGX

Koshinski Asset Management's DGX Position: Q2 2026 in Review

Koshinski Asset Management increased its Quest Diagnostics (DGX) stake by 20% in Q2 2026, buying an estimated $82.8K and bringing the position to 2,484 shares worth $526K. The position accounts for 0.03% of the portfolio, ranked #447.

Koshinski Asset Management first reported a position in DGX in Q3 2021 and has held it in 8 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Koshinski Asset Management held 2,484 shares of Quest Diagnostics worth $526K as of Q2 2026.
  • Koshinski Asset Management bought 422 Quest Diagnostics shares in Q2 2026, an estimated $82.8K.
  • Quest Diagnostics made up 0.03% of Koshinski Asset Management's portfolio in Q2 2026, its #447 holding.
  • Koshinski Asset Management first reported a position in Quest Diagnostics in Q3 2021 and has held it in 8 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.